Compare ArcelorMittal SA (MT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ArcelorMittal SA vs State Street SPDR S&P Biotech ETF — how do they compare? ArcelorMittal SA trades at $66.25 (market cap $50.01B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: ArcelorMittal SA pays a 0.91% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| MT | XBI | |
|---|---|---|
Market Cap | $50.01B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $71.65 | $164.28 |
52-Week Low | $30.39 | $85.16 |
Enterprise Value | $59.33B | — |
Dividend Yield | 0.91% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
